SE0102220D0 - Method for estimation of the amount of specific cell types - Google Patents

Method for estimation of the amount of specific cell types

Info

Publication number
SE0102220D0
SE0102220D0 SE0102220A SE0102220A SE0102220D0 SE 0102220 D0 SE0102220 D0 SE 0102220D0 SE 0102220 A SE0102220 A SE 0102220A SE 0102220 A SE0102220 A SE 0102220A SE 0102220 D0 SE0102220 D0 SE 0102220D0
Authority
SE
Sweden
Prior art keywords
amount
estimating
subtypes
cell types
specific cell
Prior art date
Application number
SE0102220A
Other languages
English (en)
Inventor
Per Venge
Original Assignee
Pharmacia Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Diagnostics Ab filed Critical Pharmacia Diagnostics Ab
Priority to SE0102220A priority Critical patent/SE0102220D0/sv
Publication of SE0102220D0 publication Critical patent/SE0102220D0/sv
Priority to AT02780858T priority patent/ATE458198T1/de
Priority to EP02780858A priority patent/EP1407266B1/en
Priority to PCT/SE2002/001214 priority patent/WO2003001205A1/en
Priority to AU2002350797A priority patent/AU2002350797B2/en
Priority to CA002447843A priority patent/CA2447843A1/en
Priority to DK02780858.3T priority patent/DK1407266T3/da
Priority to US10/178,211 priority patent/US7405047B2/en
Priority to DE60235368T priority patent/DE60235368D1/de
Priority to ES02780858T priority patent/ES2340472T3/es
Priority to JP2003507549A priority patent/JP2004532994A/ja

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0102220A 2001-06-25 2001-06-25 Method for estimation of the amount of specific cell types SE0102220D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0102220A SE0102220D0 (sv) 2001-06-25 2001-06-25 Method for estimation of the amount of specific cell types
JP2003507549A JP2004532994A (ja) 2001-06-25 2002-06-24 特定の細胞タイプの量を推定するための方法
AU2002350797A AU2002350797B2 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific cell types
EP02780858A EP1407266B1 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific neutrophil cell types
PCT/SE2002/001214 WO2003001205A1 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific cell types
AT02780858T ATE458198T1 (de) 2001-06-25 2002-06-24 Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten
CA002447843A CA2447843A1 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific cell types
DK02780858.3T DK1407266T3 (da) 2001-06-25 2002-06-24 Fremgangsmåde til estimering af mængden af specifikke neutrofile celletyper
US10/178,211 US7405047B2 (en) 2001-06-25 2002-06-24 Method for estimation of the amount of specific cell types
DE60235368T DE60235368D1 (de) 2001-06-25 2002-06-24 Verfahren zur abschätzung der anzahl an spezifischen neutrophilen zellarten
ES02780858T ES2340472T3 (es) 2001-06-25 2002-06-24 Procedimiento para estimar la cantidad de tipos celulares de neutrofilos especificos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102220A SE0102220D0 (sv) 2001-06-25 2001-06-25 Method for estimation of the amount of specific cell types

Publications (1)

Publication Number Publication Date
SE0102220D0 true SE0102220D0 (sv) 2001-06-25

Family

ID=20284572

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102220A SE0102220D0 (sv) 2001-06-25 2001-06-25 Method for estimation of the amount of specific cell types

Country Status (10)

Country Link
EP (1) EP1407266B1 (sv)
JP (1) JP2004532994A (sv)
AT (1) ATE458198T1 (sv)
AU (1) AU2002350797B2 (sv)
CA (1) CA2447843A1 (sv)
DE (1) DE60235368D1 (sv)
DK (1) DK1407266T3 (sv)
ES (1) ES2340472T3 (sv)
SE (1) SE0102220D0 (sv)
WO (1) WO2003001205A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008144850A1 (en) * 2007-05-30 2008-12-04 Advanced Diagnostic Systems Ltd Assay for determining risk of development of allergic disorders
WO2016043683A1 (en) * 2014-09-18 2016-03-24 Ciftci Ihsan Hakki A blood count device
CN114720358B (zh) * 2022-04-11 2022-09-27 浙江普罗亭健康科技有限公司 一种质谱流式血液肿瘤免疫分型中替代侧向散射光信号的抗体组合及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
JP3522865B2 (ja) * 1994-11-25 2004-04-26 株式会社いかがく 尿中白血球の検出方法
US5658745A (en) * 1995-02-17 1997-08-19 E. I. Du Pont De Nemours And Company Cell enumeration immunoassay
EP0890104B1 (en) * 1996-03-29 2001-08-01 University Of British Columbia Platelet count assay using platelet granule proteins
JP2000019170A (ja) * 1998-06-29 2000-01-21 Shima Kenkyusho:Kk 顆粒球数測定方法、白血球数測定方法及び白血球数測 定装置
AU2500800A (en) * 1999-01-14 2000-08-01 Bruce M. Boman Immunoassays to detect diseases or disease susceptibility traits
US6363802B1 (en) * 1999-03-25 2002-04-02 Coulter International Corp. Apparatus for aspirating liquid from a vessel
TWI251078B (en) * 1999-03-29 2006-03-11 Asahi Kasei Corp Method for determining a white blood cell count of a whole blood sample, based on the concentration of myeloperoxidase

Also Published As

Publication number Publication date
AU2002350797B2 (en) 2008-03-20
WO2003001205A1 (en) 2003-01-03
JP2004532994A (ja) 2004-10-28
EP1407266B1 (en) 2010-02-17
CA2447843A1 (en) 2003-01-03
DE60235368D1 (de) 2010-04-01
ES2340472T3 (es) 2010-06-04
DK1407266T3 (da) 2010-05-31
ATE458198T1 (de) 2010-03-15
EP1407266A1 (en) 2004-04-14

Similar Documents

Publication Publication Date Title
TW200600060A (en) Apparatus for the manufacture of medical devices
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
Mathur et al. An overview of methods used for estimation of time since death
BR0201823A (pt) Método para fornecimento de serviços diagnósticos clìnicos
BR0010068A (pt) Sistema de identificação do marcador fenotìpico e biológico
NO20052992D0 (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
ATE451477T1 (de) Diagnose und überwachung von hepatozellulärem karzinom
CN105699654B (zh) 皮肤角质层的ngal的表达量的用途
Ibrahim et al. A novel approach to classify risk in dengue hemorrhagic fever (DHF) using bioelectrical impedance analysis (BIA)
DE69628033D1 (de) Verfahren zur im-vitro-analyse von toxischen und allergenen substanzen
SE0102220D0 (sv) Method for estimation of the amount of specific cell types
Oral Anticoagulation Monitoring Study Group Prothrombin measurement using a patient self-testing system. Oral Anticoagulation Monitoring Study Group
JP2006509500A5 (sv)
CN106093024A (zh) 一种检测脑卒中发病风险以及发病的生物标志物的检测方法及其应用
US20240081724A1 (en) Wearable point-of-care devices for assessing immune activity from interstitial fluid and methods of use thereof
ATE382678T1 (de) Verfahren zur diagnose von rickettsia pulicis
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
ATE499611T1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
Garewal et al. Saliva: A Diagnostic Marker in Health and Disease
Chng et al. Healthy adults demonstrate less skin reactivity to commercial extracts of commonly ingested food than to D. farinae
RU2001128868A (ru) Способ диагностики наружного генитального эндометриоза
DK1454137T3 (da) Anvendelse af en mærket ligand med specificitet for det humane CD4-molekyle
Okogun et al. Evaluation of serum proteins in some immuno-compromised patients in Auchi, Edo State of Nigeria
Rodgers et al. Body-Worn Microfluidic Sensors
WO2005059554A8 (en) Puma, phosphorylated p53 and p38 map kinase as markers for hiv-1-induced apoptosis in circulating t cells of infected patient